Dos, Don’ts, Precautions & Relapse of Covid-19

Journal Title: Open Access Journal of Pharmaceutical Research - Year 2020, Vol 4, Issue 3

Abstract

Due to the current scenario, created by COVID-19 pandemic, in a situation, where there is no accurate medicine or vaccine available, all we can do is to practice seriously dos, don’t, take precautions and have an absolute idea about its relapse . This mini article is an attempt to cover above mentioned factors.

Authors and Affiliations

Pal RS*, Saraswat N, Pal Y, Wal P and Wal A

Keywords

Related Articles

Impact of GST on Pharmaceuticals An Overview

GST also known as the goods and service tax is defined as the giant tax structure designed to support and enhances the economic growth of our country. More than 150 countries have implemented GST so far. GST is an indire...

Chikungunya Emerging Health Crises in Pakistan: Are we Going in the Right Direction

The unstable health care system of Pakistan saw a major setback in the form of dengue outbreak in 2011. Despite massive governmental efforts, with each passing year dengue continues to cause significant morbidity and mo...

Unveiling the Therapeutic Landscape of Oseltamivir: Exploring Drug Utilization, Adverse Reactions and Interactions with Comorbidities-A Prospective Study

Objective: This study aimed to investigate adverse drug reactions (ADRs) associated with Oseltamivir in the presence of various co-morbidities. The objective was to analyze prescription patterns, administration rational...

Machine Learning Applications in Drug Discovery and Development

Machine learning has emerged as a powerful tool in the field of drug discovery and development, revolutionizing the way pharmaceutical research is conducted. This abstract provides a concise overview of the key applicat...

Simultaneous Determination of Ranitidine Hydrochloride and Ondansetron Hydrochloride in Bulk Drug and Tablet Dosage Form by UV Spectrophotometry

A simple, accurate and economic UV Spectrophotometric method was developed for simultaneous estimation of Ranitidine Hydrochloride (RNH) and Ondansetron Hydrochloride (ODH) in bulk drug and tablet dosage form. Distilled...

Download PDF file
  • EP ID EP748474
  • DOI 10.23880/oajpr-16000214
  • Views 40
  • Downloads 0

How To Cite

Pal RS*, Saraswat N, Pal Y, Wal P and Wal A (2020). Dos, Don’ts, Precautions & Relapse of Covid-19. Open Access Journal of Pharmaceutical Research, 4(3), -. https://europub.co.uk./articles/-A-748474